Monopar Therapeutics Inc. (MNPR) NASDAQ

82.50

-0.58(-0.70%)

Updated at November 11 09:33AM

Currency In USD

Valuation

Market Cap83.38M
Enterprise Value37.56M
P/E Ratio-0.44
PEG Ratio-0.05
Price/Sales Ratio0
Price/Book Ratio0.01
Enterprise/Revenue0
Enterprise/EBITDA2,246.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.1

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-15.59M
Net Income-15.59M
Diluted EPS-4.11

Balance Sheet

Total Cash39.5B
Total Cash/Share5,644.68
Total Debt80.37M
Total Debt/Equity0
Current Ratio33.94
Book Value Per Share7,459.46

Price History

52-Week Change398.68
52-Week High105
52-Week Low16.25
Moving Average 50 Days73.59
Moving Average 200 Days46.66

Statistics

Average Volume77,673
Shares Outstanding6.17M
% Held by Institutions45.39

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateAugust 13, 2024